These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27841100)

  • 1. Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats.
    Maheshwari R; Balaraman R; Sen AK; Shukla D; Seth A
    Ren Fail; 2017 Nov; 39(1):130-139. PubMed ID: 27841100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
    Eitah HE; Maklad YA; Abdelkader NF; Gamal El Din AA; Badawi MA; Kenawy SA
    Toxicol Appl Pharmacol; 2019 Feb; 365():30-40. PubMed ID: 30576699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of altered antioxidant enzymes activity and glomerulosclerosis by coenzyme Q10 in alloxan-induced diabetic rats.
    Ahmadvand H; Tavafi M; Khosrowbeygi A
    J Diabetes Complications; 2012; 26(6):476-82. PubMed ID: 22795334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes.
    Marques C; Gonçalves A; Pereira PMR; Almeida D; Martins B; Fontes-Ribeiro C; Reis F; Fernandes R
    Life Sci; 2019 Oct; 234():116738. PubMed ID: 31398418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sitagliptin's renoprotective effect in a diabetic nephropathy model in rats: The potential role of PI3K/AKT pathway.
    Mohamed RH; Sedky AA; Hamam GG; Elkhateb L; Kamar SA; Adel S; Tawfik SS
    Fundam Clin Pharmacol; 2022 Apr; 36(2):324-337. PubMed ID: 34735026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: a possible role of HIF-1α and nitric oxide.
    Abdelzaher WY; Rofaeil RR; Ali DME; Attya ME
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):603-614. PubMed ID: 31773182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dipeptidyl peptidase-4 inhibitor sitagliptin ameliorates renal injury in type 1 diabetic mice
    Li L; Lian X; Wang Z; Zheng J; Liu J; Chu Y; Teng Y; Zhang Z
    Pharmazie; 2019 Apr; 74(4):239-242. PubMed ID: 30940309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Improvement of Oxidative Stress in Diabetic Rats by Ubiquinone-10 and Ubiquinol-10 and Bioavailability after Short- and Long-Term Coenzyme Q10 Supplementation.
    Prangthip P; Kettawan A; Posuwan J; Okuno M; Okamoto T
    J Diet Suppl; 2016 Nov; 13(6):647-59. PubMed ID: 27064932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic intervention of coenzyme Q10 and its combination with pioglitazone on the mRNA expression level of adipocytokines in diabetic rats.
    Maheshwari RA; Parmar GR; Hinsu D; Seth AK; Balaraman R
    Life Sci; 2020 Oct; 258():118155. PubMed ID: 32735887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A; El-Moselhy MA; Taye A; Khalifa MM
    Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats.
    Rauscher FM; Sanders RA; Watkins JB
    J Biochem Mol Toxicol; 2001; 15(1):41-6. PubMed ID: 11170314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sitagliptin ameliorates diabetic nephropathy by upregulating renal nephrin and podocin expression through modulation of adipokines levels.
    Ashraf A; Akhtar T; Shabbir A; Aftab U; Shahzad M
    Fundam Clin Pharmacol; 2023 Jun; 37(3):549-555. PubMed ID: 36594370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochanin-A has antidiabetic, antihyperlipidemic, antioxidant, and protective effects on diabetic nephropathy via suppression of TGF-β1 and PAR-2 genes expression in kidney tissues of STZ-induced diabetic rats.
    Amri J; Alaee M; Babaei R; Salemi Z; Meshkani R; Ghazavi A; Akbari A; Salehi M
    Biotechnol Appl Biochem; 2022 Oct; 69(5):2112-2121. PubMed ID: 34652037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin improves renal function in diabetic nephropathy in male Sprague Dawley rats through upregulating heme oxygenase-1 expression.
    Wang J; Hu L; Chen Y; Fu T; Jiang T; Jiang A; You X
    Endocrine; 2019 Jan; 63(1):70-78. PubMed ID: 30128961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
    Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA
    PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats.
    Sharma S; Anjaneyulu M; Kulkarni SK; Chopra K
    Pharmacology; 2006; 76(2):69-75. PubMed ID: 16286809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.
    Abd El Motteleb DM; Abd El Aleem DI
    Clin Exp Pharmacol Physiol; 2017 Apr; 44(4):509-521. PubMed ID: 28079268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.